Developing safe therapies from human pluripotent stem cells
MK Carpenter, J Frey-Vasconcells, MS Rao - Nature biotechnology, 2009 - nature.com
MK Carpenter, J Frey-Vasconcells, MS Rao
Nature biotechnology, 2009•nature.comDeveloping safe therapies from human pluripotent stem cells | Nature Biotechnology Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited
support for CSS. To obtain the best experience, we recommend you use a more up to date
browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure
continued support, we are displaying the site without styles and JavaScript. Advertisement
Nature Biotechnology View all journals Search My Account Explore content About the journal …
main content Thank you for visiting nature.com. You are using a browser version with limited
support for CSS. To obtain the best experience, we recommend you use a more up to date
browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure
continued support, we are displaying the site without styles and JavaScript. Advertisement
Nature Biotechnology View all journals Search My Account Explore content About the journal …
Translation of human pluripotent stem cells into cell therapies will require the development of standardized tests for product consistency, stability, tumorigenicity, toxicity and immunogenicity.
nature.com